Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

PHGE US Equity

BiomX Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1739174 · FY ends Dec 31
$0.14
+0.00 (+0.51%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Nantahala Capital Management, LLCsec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Centaurus Investments Ltdsec.gov ↗
2026-08-118-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-08-118-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-288-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-07-288-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-108-K 8.01Other eventssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-10

Every row is a filed document, checked against its EDGAR index.